Texier B, Bedin C, Roubaty C, Brezin C, Charreire J
INSERM U.283, Hôpital Cochin, Paris, France.
J Immunol. 1992 Jan 15;148(2):439-44.
A clonotypic mAb, AG7, has been prepared from splenocytes of CBA/J mice immunized with a cytotoxic T cell hybridoma, HTC2, specific for a pathogenic epitope of the thyroglobulin molecule in association with class I MHC Ag. AG7 binds to HTC2 cells but not to the other T cell hybridomas tested. Moreover, when used in functional studies, AG7 blocks the HTC2 capacity of specific target lysis. It also reacts with a determinant that comodulates with the CD3 Ag present on the surface of HTC2 cells. Immunoprecipitation of 125I-labeled solubilized HTC2 membranes demonstrated two bands located at 90 and 72 kDa under nonreducing conditions, which became a 46-kDa band under reducing conditions. Finally, when AG7 is injected into CBA/J mice, on day -1 before immunization with the pathogenic tryptic fragments of the thyroglobulin molecule, experimental autoimmune thyroiditis is abrogated. Thus, one of the multiple potential mechanisms of the protective immunity against EAT induced by HTC2 cells that we previously proposed, i.e., the generation of anti-clonotypic antibodies to HTC2 TCR, seems apparent.
一种克隆型单克隆抗体AG7是从用细胞毒性T细胞杂交瘤HTC2免疫的CBA/J小鼠脾细胞中制备的。HTC2对与I类MHC抗原相关的甲状腺球蛋白分子的致病表位具有特异性。AG7与HTC2细胞结合,但不与所测试的其他T细胞杂交瘤结合。此外,在功能研究中使用时,AG7可阻断HTC2特异性靶细胞裂解的能力。它还与HTC2细胞表面存在的与CD3抗原共同调节的决定簇发生反应。对125I标记的可溶性HTC2膜进行免疫沉淀,在非还原条件下显示出位于90和72 kDa的两条带,在还原条件下变为46 kDa的一条带。最后,当在用甲状腺球蛋白分子的致病胰蛋白酶片段免疫前一天(第-1天)将AG7注射到CBA/J小鼠体内时,实验性自身免疫性甲状腺炎被消除。因此,我们之前提出的HTC2细胞诱导的针对实验性自身免疫性甲状腺炎的保护性免疫的多种潜在机制之一,即产生针对HTC2 TCR的抗克隆型抗体,似乎是显而易见的。